Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.
ML is poised to become faster and more accessible by 2026. Simply having the support of GenAI already gives it an advantage over other AI-based solutions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results